1-4 of 4
Ali R. Jazirehi, Ph.D.
Close
Sort by
Journal Articles

Rituximab-Mediated Inhibition of the Constitutive NIK/IKK/IκB/NF-κB Signaling Pathway in Non-Hodgkin’s Lymphoma (NHL) B-Cell Lines: Role in Chemo-Sensitization.

Ali R. Jazirehi, Ph.D., Sara Huerta-Yepez, Ph.D., Genhong Cheng, Ph.D., Benjamin Bonavida, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 288.
https://doi.org/10.1182/blood.V104.11.288.288
Published: 2004
Journal Articles

Rituximab-Mediated Inhibition of the Transcription Repressor Yin-Yang 1 (YY1) in NHL B Cell Lines: Upregulation of Fas Expression and Sensitization to Fas-Induced Apoptosis.

Mario I. Vega, Ph.D., Sara Huerta-Yepez, Ph.D., Ali R. Jazirehi, Ph.D., Hermes Garban, Ph.D., Benjamin Bonavida, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 287.
https://doi.org/10.1182/blood.V104.11.287.287
Published: 2004
Journal Articles

Cellular and Molecular Characterization of Rituximab-Resistant CD20 + NHL Ramos (Ramos RR1) and Daudi (Daudi RR1) Clones: Development of Cross-Resistance to Cytotoxic Stimuli.

Ali R. Jazirehi, Ph.D., Benjamin Bonavida, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3410.
https://doi.org/10.1182/blood.V104.11.3410.3410
Published: 2004
Journal Articles

Sensitization of Rituximab-Resistant Ramos RR1 and Daudi RR1 Clones to Various Chemotherapeutic Drugs by a Novel Nuclear Factor-κB Activation Inhibitor.

Ali R. Jazirehi, Ph.D., Kazeo Umezawa, Ph.D., Benjamin Bonavida, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 83.
https://doi.org/10.1182/blood.V104.11.83.83
Published: 2004